Human papillomavirus (HPV)-positive HNSCC is more likely to exhibit an immunologically active TME with more PD-1-positive CD8 T cells than HPV-negative disease, highlighting the potential for improved activity in this population. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.